Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
The Journal of Biological Chemistry|October 18, 2005
Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous systemAmbreena Siddiq, Issam A Ayoub, Juan C Chavez, et al.
Journal of Neuroimmunology|May 12, 2005
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitisSandra Camelo, Antonio H Iglesias, Daehee Hwang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 10, 2016
Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like DiseaseManuj Ahuja, Navneet Ammal Kaidery, Lichuan Yang, et al.
Scientific Reports|February 10, 2021
Machine intelligence identifies soluble TNFa as a therapeutic target for spinal cord injuryJ R Huie, A R Ferguson, N Kyritsis, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 19, 2004
Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's diseaseRobert J Ferrante, Hoon Ryu, James K Kubilus, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 6, 2011
Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegenerationSama F Sleiman, Brett C Langley, Manuela Basso, et al.
Cell|May 7, 2019
Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat StrokeIshraq Alim, Joseph T Caulfield, Yingxin Chen, et al.
ACS Chemical Neuroscience|January 18, 2018
Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 InhibitorsIrina N Gaisina, Sue H Lee, Navneet A Kaidery, et al.
Antioxidants & Redox Signaling|April 29, 2014
Antihelminthic benzimidazoles are novel HIF activators that prevent oxidative neuronal death via binding to tubulinHossein Aleyasin, Saravanan S Karuppagounder, Amit Kumar, et al.
Pageof 16